Neurology Devices are specialized surgical devices used for the treatment of disease or conditions of the Central Nervous System (CNS) and spine. Neuromodulation devices are implantable electrical devices that are used to typically treat chronic pain, by modulating pathways in the spinal cord leading to blocking transmission of pain signals to the brain. GlobalData uses proprietary data and analytics to provide a comprehensive report on the neuromodulation devices devices market, including market shares of different players within Austria. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the neuromodulation devices market in Austria was Medtronic followed by Boston Scientific, Nevro, Abbott Laboratories, LivaNova, B. Braun Melsungen, IntraPace, Xavant Technology and ReShape Lifesciences.
Neuromodulation devices include Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS), Peripheral Nerve Stimulators (PNS) and Vagus Nerve Stimulators (VNS). A DBS is a device that is comprised of a brain-oriented pacemaker (an implantable pulse generator) that sends electrical stimulation through surgically implanted electrodes to specific targets in the brain. GES are utilized to treat gastroparesis, a medical condition where weak muscular contractions (peristalsis) of the stomach results in food and liquid remaining in the stomach for an extended period, leading to irregular absorption of nutrients, inadequate nutrition, and poor glycemic control. An SNS is a device comprised of a subcutaneously implanted electrical pacemaker that sends low electrical stimulation through surgically implanted electrodes to target the sacral nerve. An SCS is a device that comprises a surgically implanted electrical pacemaker and electrodes that connect to the spinal cord to treat chronic pain disorders. A PNS is a device, similar to the SCS that is used to treat chronic pain disorders. A VNS is a device comprised of an electrical pacemaker that sends electrical stimulation through surgically implanted electrodes to target the vagus nerve. Lead is a set of thin wires covered with a protective coating. It carries the therapy signal to the electrodes that deliver stimulation to the target of interest.
The value of the neuromodulation devices devices market within Austria was expected to be over $10m in 2023.
For the latest complete market share analysis of neuromodulation devices device market in Austria, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
